SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,717,146 | +2.2% | 22,415 | -3.4% | 0.02% | +7.1% |
| Q2 2023 | $2,658,353 | -28.9% | 23,213 | -14.4% | 0.01% | -33.3% |
| Q1 2023 | $3,736,709 | +3.2% | 27,111 | -5.4% | 0.02% | -43.2% |
| Q4 2022 | $3,622,522 | +57.8% | 28,666 | +38.0% | 0.04% | +37.0% |
| Q3 2022 | $2,296,000 | +55.8% | 20,767 | +8.6% | 0.03% | +68.8% |
| Q2 2022 | $1,474,000 | -2.6% | 19,129 | -1.3% | 0.02% | +23.1% |
| Q1 2022 | $1,514,000 | -18.1% | 19,379 | -5.6% | 0.01% | -13.3% |
| Q4 2021 | $1,849,000 | +15.1% | 20,535 | +18.2% | 0.02% | +7.1% |
| Q3 2021 | $1,606,000 | +26.7% | 17,370 | +6.5% | 0.01% | +27.3% |
| Q2 2021 | $1,268,000 | +38.3% | 16,306 | +32.6% | 0.01% | +57.1% |
| Q1 2021 | $917,000 | -61.4% | 12,299 | -50.7% | 0.01% | -12.5% |
| Q4 2020 | $2,374,000 | – | 24,926 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |